Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Gulf Keystone to resume exports through Iraq-Turkey pipeline

(Sharecast News) - Shares in Gulf Keystone Petroleum rallied on Friday, after the London-listed oil and gas producer confirmed it would resume international Kurdistan crude exports. A protracted row between Ankara and Baghdad led to the 600 mile Iraq-Turkey pipeline - which runs from Kirkuk in Iraq to the port city of Ceyhan in Turkey - being shut being for two years.

However, earlier this week it was announced that exports would resume after a deal was signed between the Iraqi and Kurdish governments. Turkey also confirmed it is willing to restart the pipeline.

Gulf said it - along with various other oil companies - had signed agreements with both the Kurdistan regional government and Iraq enabling the resumption of international crude exports from Kurdistan.

Pipeline exports from the Shaikan field are now expected to restart "in the coming days", it added.

As at 1100 BST, shares in firm were up 5% at 217.94, having come off earlier highs of 224p.

Bermuda-registered Gulf is exclusively focused on the semi-autonomous Kurdistan region of Iraq.

Jon Harris, chief executive, said: "The restart of Kurdistan crude exports via the pipeline is a historic milestone for Gulf Keystone, Kurdistan and Iraq that is expected to unlock significant value for all stakeholders.

"A return to international sales prices will be transformative for the company's cash flow, while we believe the agreements [with Kurdistan and Iraq], along with the production sharing contracts, will facilitate long-term profitable investment in Kurdistan's oil and gas reserves, of which the Shaikan field accounts for a significant proportion."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.